Farmaceutica Remedia S.A.
ISIN: RORMAHACNOR2 | Ticker: RMAH | LEI: 2549001TDHDVU72MQS59
Country: Romania
Listed on the Bucharest Stock Exchange since 1996 – STANDARD Category, symbol RMAH, Farmaceutica REMEDIA S.A., a member of the group of companies, is specialized in sales and distribution of medicines, promotion and marketing activities in the healthcare sector, and it is one of the TOP 10 distributors on the pharmaceutical market.
Farmaceutica REMEDIA Distribution & Logistics SRL – specialized in pharmaceuticals wholesale activities, marketing and promotion activities in the healthcare sector, operates the sales through 6 (six) logistic centers by the following business lines:
– Distribution Division: sales to the pharmacies and other key accounts.
– Hospital Division: sales to the public and private hospitals and clinics.
1991
Served areaEurope
HeadquartersBd. Nicolae Balcescu nr. 2, 330040 Deva, Hunedoara – Romania
| Line item in (ron) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Assets | N/A | 244,463,046.00 | 251,072,707.00 | 286,204,891.00 |
| Noncurrent Assets | N/A | 40,256,854.00 | 42,655,089.00 | 44,484,546.00 |
| Property Plant And Equipment | N/A | 28,316,243.00 | 21,313,782.00 | 24,760,379.00 |
| Investment Property | N/A | 8,204,038.00 | 18,657,330.00 | 16,545,703.00 |
| Investments In Subsidiaries | N/A | 289,520.00 | 292,320.00 | 588,620.00 |
| Investments In Joint Ventures | N/A | 5,316.00 | 5,316.00 | 5,916.00 |
| Noncurrent Finance Lease Receivables | N/A | N/A | 0.00 | 0.00 |
| Current Assets | N/A | 202,969,618.00 | 206,230,930.00 | 240,890,648.00 |
| Inventories | N/A | 35,077,188.00 | 40,600,994.00 | 46,262,314.00 |
| Current Trade Receivables | N/A | 130,201,748.00 | 137,629,452.00 | 173,704,309.00 |
| Current Prepaid Expenses | N/A | 1,236,574.00 | 2,186,689.00 | 829,696.00 |
| Other Current Receivables | N/A | 3,340,268.00 | 3,782,734.00 | 2,840,680.00 |
| Cash and cash equivalents | N/A | 34,350,414.00 | 24,217,749.00 | 18,083,345.00 |
| Equity And Liabilities | N/A | 244,463,047.00 | 251,072,707.00 | 286,204,891.00 |
| Equity | 49,061,523.00 | 79,830,650.00 | 68,223,569.00 | 68,433,434.00 |
| Issued Capital | N/A | 10,921,209.00 | 9,860,311.00 | 9,860,311.00 |
| Retained Earnings | N/A | -3,632,398.00 | 6,742,374.00 | 12,477,605.00 |
| Share Premium | N/A | 757,485.00 | 757,485.00 | 757,485.00 |
| Other Reserves | N/A | 34,803,056.00 | 44,055,097.00 | 39,953,756.00 |
| Liabilities | N/A | 164,632,396.00 | 182,849,139.00 | 217,771,457.00 |
| Noncurrent Liabilities | N/A | 2,246,739.00 | 2,544,268.00 | 3,175,842.00 |
| Deferred Tax Liabilities | N/A | 2,246,739.00 | 0.00 | 0.00 |
| Current Liabilities | N/A | 162,385,658.00 | 180,304,871.00 | 214,595,615.00 |
| Current Provisions | N/A | 0.00 | 217,307.00 | 217,307.00 |
| Trade And Other Current Payables | N/A | 159,154,783.00 | 176,037,147.00 | 209,969,435.00 |
| Other Current Liabilities | N/A | 2,238,576.00 | 2,761,752.00 | 3,054,580.00 |
| Current Borrowings And Current Portion Of Noncurrent Borrowings | N/A | 0.00 | 0.00 | 0.00 |
| Line item in (ron) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Revenue | 483,115,658.00 | 478,170,674.00 | 540,045,595.00 |
| Revenue From Sale Of Goods | 439,903,203.00 | 474,530,058.00 | 530,960,392.00 |
| Revenue From Dividends | 66,733.00 | 140,333.00 | 79,826.00 |
| Revenue From Contracts With Customers | 441,478,105.00 | 477,102,652.00 | 535,850,640.00 |
| Raw Materials And Consumables Used | 2,585,406.00 | 1,974,561.00 | 3,485,778.00 |
| Cost Of Merchandise Sold | 399,816,634.00 | 444,975,920.00 | 495,526,556.00 |
| Employee Benefits Expense | 27,575,662.00 | 19,465,138.00 | 22,132,735.00 |
| Wages And Salaries | 24,616,138.00 | 17,271,209.00 | 19,309,357.00 |
| Social Security Contributions | 1,151,057.00 | 795,612.00 | 903,217.00 |
| Other Employee Expense | 1,808,468.00 | 1,398,317.00 | 1,920,161.00 |
| Depreciation Amortisation And Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | 2,645,174.00 | 1,791,200.00 | 4,067,397.00 |
| Depreciation Expense | 408,691.00 | 423,647.00 | N/A |
| Amortisation Expense | 1,103,087.00 | 1,207,986.00 | 4,016,528.00 |
| Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | 1,133,396.00 | 168,758.00 | 330,175.00 |
| Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | 1,133,396.00 | 168,758.00 | 330,175.00 |
| Tax Expense Other Than Income Tax Expense | 771,985.00 | 990,377.00 | 1,934,291.00 |
| Other Expense By Nature | 5,468,528.00 | 344,175.00 | 2,189,505.00 |
| Profit Loss From Operating Activities | 42,862,583.00 | 8,790,019.00 | 6,745,946.00 |
| Finance Income | 312,150.00 | 220,698.00 | 844,833.00 |
| Finance Costs | 406,116.00 | 377,581.00 | 532,927.00 |
| Profit Loss Before Tax | 42,768,616.00 | 8,633,136.00 | 7,057,852.00 |
| Income Tax Expense Continuing Operations | 4,997,042.00 | 1,399,978.00 | 1,248,719.00 |
| Profit (loss) | 37,771,574.00 | 7,233,158.00 | 5,809,133.00 |
| Profit Loss Attributable To Owners Of Parent | 37,771,574.00 | 7,233,158.00 | 5,809,133.00 |
| Line item in (ron) | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|
| Profit (loss) | 37,771,574.00 | 7,233,158.00 | 5,809,133.00 |
| Interest Paid Classified As Operating Activities | N/A | 0.00 | 65,890.00 |
| Interest Received Classified As Operating Activities | N/A | 22,071.00 | 386,605.00 |
| Income Taxes Paid Refund Classified As Operating Activities | N/A | 1,548,096.00 | 1,285,506.00 |
| Other Inflows Outflows Of Cash Classified As Operating Activities | N/A | 5,304,510.00 | 24,622,509.00 |
| Cash Flows From Used In Operating Activities | N/A | -2,630,742.00 | 1,988,341.00 |
| Proceeds From Other Longterm Assets Classified As Investing Activities | N/A | 480,112.00 | 197,700.00 |
| Purchase Of Other Longterm Assets Classified As Investing Activities | N/A | 36,569.00 | 38,016.00 |
| Dividends Received Classified As Investing Activities | N/A | 140,333.00 | 79,826.00 |
| Interest Received Classified As Investing Activities | N/A | N/A | 0.00 |
| Cash Flows From Used In Investing Activities | N/A | 583,876.00 | 239,510.00 |
| Payments From Changes In Ownership Interests In Subsidiaries | N/A | N/A | 0.00 |
| Proceeds From Borrowings Classified As Financing Activities | N/A | 0.00 | 0.00 |
| Cash Flows From Used In Financing Activities | N/A | -13,347,283.00 | -4,524,864.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | 7,533.00 | -54,864.00 |
| Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | N/A | -10,132,665.00 | -6,273,695.00 |
| Cash and cash equivalents | 34,350,414.00 | 24,217,749.00 | 18,083,345.00 |
Please note that some sums might not add up.
RORMAHACNOR2
LEI2549001TDHDVU72MQS59
SectorHealth Care Equipment & Services
IndustryHealth Care Providers & Services
Sub-IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.